Preterm Labour Flashcards
What is the definition of moderate / late preterm labour?
32-36+6
What is the definition of very preterm labour?
28 - 31+6
What is the definition of extreme preterm labour?
Prevalence?
<28/40
0.5% births
What proportion of PTB is iatrogenic?
20-40%
What are four possible mechanisms for spontaneous PTL?
- Premature activation of maternal or fetal HPA axis
- Exaggerated inflammatory response or infection
- Decidual haemorrhage
- Pathological uterine distension
What are the risk factors for PTB (20!)
Previous PTB (15-30% recurrence, usually at same gestation)
Multiple gestation
IVF
Uterine anomaly including fibroids
Previous cervical surgery (particularly LLETZ >10mm or ≥2 LLETZ, cone biopsy)
Previous Evac/D&C - less association with medical Rx miscarriage/MTOP
PPROM
Previous 2nd trimester abortion
CS at fully
Polyhydramnios
Genital tract infection
Asymptomatic bacteruria
Systemic infection
Maternal chronic disease
APH - 1st trimester / praevia / abruption
Smoking
Extremes of age
Anaemia
IUGR
Fetal anomaly (or demise)
Social factors
Genetic factors
At what gestation (of prematurity) should you NOT do FBS and FSE?
< 34/40
What was the finding of the Cochrane 2013review looking at
- prenatal administration of progesterone to prevent PT in women considered to be at risk of PT
Progesterone reduced PTB and improved neonatal outcomes for:
- women with a history of preterm birth or second trimester miscarriage
- women with a shortened cervix <25mm
- women who presented threatened pre-term labour
No significant evidence for its use in multiple pregnancies
Note OPTIMUM trial completed after this- RCT looking at the use of progesterone in these situations, found no benefit
`What was the finding of the Cochrane review looking at
- combinations of tocolytic drugs for inhibiting PTL?
Unclear whether combination therapy better than single tocolytic therapy
What was the finding of the Cochrane review looking at
- Calcium channel blockers for inhibiting PTL?
Benefits over placebo with regard to
- number of women who birthed within 48 hours of starting treatment
- serious neonatal morbidity and very/extrreme preterm birth rates
- maternal adverse effects when compared to betamimetics
but NO difference in perinatal mortality
Benefits over betamimetics, ORAs and MgSO4
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002255.pub2/full
What was the finding of the Cochrane 2019 review looking at
- antibiotics for asymptomatic bacteruria in pregnancy?
Overall poor quality data but may reduce:
- risk of pyelonephritis
- preterm birth rate
- low birth weight
What was the finding of the Cochrane review looking at
- antibiotics for BV in pregnancy
Can eradicate BV, but overall risk of PTB was not reduced
What was the finding of the Cochrane review looking at
- effect of umbilical cord clamping in PTB
Delayed >30 seconds, rather than early, cord clamping may reduces the risk of death before discharge for babies born preterm.
Other outcomes were not significant.
Other studies have found DCC reduces need for blood transfusion, NEC and IVH in preterm babies.
At 23/40, what are the
- survival rates
- survival without major/minor morbidity
Survival rate - 60%
At 24/40, what are the
- survival rates
- survival without major/minor morbidity
Survival: 70-80%
At 25/40, what are the
- survival rates
- survival without major/minor morbidity
Survival rate: 80-85%
What is the mechanism by which steroids help lung development?
- Lung maturation - thinning of alveoli septum and differentiation of alvioli
- Induction of type 2 pneumocytes - increased surfactant production to reduce surface tension and pressure required to inflate lungs
- Increased NO production, causing vasodilation and improving pulmonary blood flow
- Increased epithelial Na channel expression - to promote movement of fluid from alveolar space to the interstitium
Until what gestation, should you consider rescue / repeat dose steroids?
How can repeats be prescribed?
Up till 32+6/40
- Delivery expected within 7 days (even if likely within 24 hours)
- Last dose >7 days ago
- As single dose repeat, up to a maximum of 3 repeats
- As a repeat course of 2 dose 24 hours apart, but NO further repeat doses after
What is the role of steroids prior to El LSCS
Can use past 34+6/40 “if there is known fetal lung maturity” and planned CS (RANZCOG/Liggins)
Aim CS ≥39/40
ASTECS 2005 Landmark Trial:
- steroids significantly reduced SCBU/NICU admissions for respiratory distress RR=0.46
- Reduction in RDS and TTN though not statistically significant
- the benefits reduce with increasing gestation - recommendation to delay ELCS to >39wk if possible
-
ASTECS follow-up study (2013):
- Following ACS administration no difference in school achievement of neurodevelopment outcome
What were the findings of the 2020 Cochrane Review looking at antenatal corticosteroids for accelerating fetal lung maturation in women at risk of PTB
- Looked at steroids for suspected delivery prior to 37 weeks
- Outcomes:
- Perinatal mortality RR 0.85
- RDS RR 0.71
- Neonatal death RR 0.78
Likely reduction in:
- IVH RR 0.58
- Childhood developmental delay RR 0.5
- Little to no effect on birthweight (-14g, wide CIs)
- Maternal outcomes, chorioamnionitis, endometritis - no effect
- Subgroup analyses key points
- No difference in outcomes between the 2 overlapping subgroups 1) gestation <35+0, and 2) gestation 34-36+6
- No difference in outcome when single course antenatal steroids vs weekly steroids as long as perceived risk of preterm birth
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004454.pub4/full